PROSTATIC ARTERY EMBOLIZATION MARKET ANALYSIS

Market News

Key Developments-

1. In 2018, Embolx, Inc., a medical device company, announced CE certification for its next generation of sniper balloon occlusion micro-catheters for treatment of enlarged prostate and cancerous tumors.
2. In 2019, QX Medicals, a medical device company, acquired the rights of bioresorbable embolic technology developed by researchers at the University of Minnesota. This bioresorbable embolic technology is are used by interventional radiologist for prostatic artery embolization.